SYNFINGER

Welcome to the Brand page for “SYNFINGER”, which is offered here for Cells for medical use; small molecule titratable switches for medical use;medical treatment involving small molecule titratable switches; cell therapy;platform as as service (paas) for technologies based on small molecule titratable switches for cell therapies; research and development in the field of molecules, switches and cells;.

Its status is currently believed to be active. Its class is unavailable. “SYNFINGER” is believed to be currently owned by “Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis”.


Owner:
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Owner Details
Description:
Cells for medical use; small molecule titratable switches for medical use;Medical treatment involving small molecule titratable switches; cell therapy;Platform as as service (PaaS) for technologies based on small molecule titratable switches for cell therapies; research and development in the field of molecules, switches and cells;
Categories: CELLS MEDICAL USE